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Background: The World Health Organization (WHO) declared human tuberculosis (TB) a global health emergency
and launched the “Global Plan to Stop Tuberculosis” which aims to save a million lives by 2015. Global control of TB
is increasingly dependent on rapid and accurate genetic typing of species of the Mycobacterium tuberculosis (MTB)
complex including M. tuberculosis. The aim of this study was to identify and genetically characterize the MTB
isolates circulating in the West Bank, Palestinian Territories. Genotyping of the MTB isolates from patients with
pulmonary TB was carried out using two molecular genetic techniques, spoligotyping and mycobacterial
interspersed repetitive units-variable number of tandem repeat (MIRU-VNTR) supported by analysis of the MTB
specific deletion 1 (TbD1).
Findings: A total of 17 MTB patterns were obtained from the 31 clinical isolates analyzed by spoligotyping;
corresponding to 2 orphans and 15 shared-types (SITs). Fourteen SITs matched a preexisting shared-type in the
SITVIT2 database, whereas a single shared-type SIT3348 was newly created. The most common spoligotyping profile
was SIT53 (T1 variant), identified in 35.5 % of the TB cases studied. Genetic characterization of 22 clinical isolates via
the 15 loci MIRU-VNTR typing distinguished 19 patterns. The 15-loci MIT144 and MIT145 were newly created within
this study. Both methods determined the present of M. bovis strains among the isolates.
Conclusions: Significant diversity among the MTB isolates circulating in the West Bank was identified with SIT53-T1
genotype being the most frequent strain. Our results are used as reference database of the strains circulating in our
region and may facilitate the implementation of an efficient TB control program.
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Background
Tuberculosis (TB) caused by Mycobacterium tuberculosis
(MTB) complex persists as one of the most important
public health problems worldwide, despite the global
efforts to control and eradicate this disease. The World
Health Organization (WHO) has declared that TB is a
global epidemic with high morbidity and mortality, espe-
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reproduction in any medium, provided the orbeen made in the last decade in TB diagnostics and con-
trol programs (http://www.who.int/tb/laboratory/en/).
Rapid detection and adequate therapy to prevent MTB
transmission are key factors in TB control programs. In
the last years, molecular typing approaches have greatly
enhanced our understanding of TB epidemiology by in-
dicating possible epidemiological links between TB
patients and by detecting suspected outbreaks [1]. Spoli-
gotyping, an identification method based on the direct
repeat (DR) region pattern, allows simultaneous strain
differentiation of MTB in clinical specimens without the
need for culture [2]. The clinical usefulness of spoligo-
typing is determined by its rapidity, both in detecting
causative TB pathogens and in providing epidemiologic
information on strain identities. The mycobacterialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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repeats (MIRU-VNTR) typing has been shown to be a reli-
able and reproducible method with high discriminatory
power to distinguish between MTB strains [1]. A combin-
ation of the two methods has been used to replace typing
via restriction fragment length polymorphisms based on
the insertion sequence IS6110. Importantly, some muta-
tions which have been described in MTB genes that are
associated with resistance to rifampin (RIF) or isonizide
(INH) were found to be specific to particular strain families
[3].
In the West Bank, with a population of approximately
2.44 million inhabitants, TB incidence rate is low. This can
be explained as representing the precise incidence of the
disease or a result of a misdiagnosis due to the low sensitiv-
ity of the diagnostic methods which are primarily based on
microscopic examination of self-expectorated sputum
stained for acid fast bacilli. Several cases of multi drug re-
sistance (MDR) and non-compliance to therapy were
reported in the last few years [4,5]. This recognized that the
deterioration in the economical, nutritional and health
situations caused by regional conflict increases the likeli-
hood of an increase in misdiagnosed patients and the rise of
MDR TB case. The TB diagnostic criteria are well estab-
lished and practiced in the Palestinian Territories. Pulmon-
ary TB is suspected among patients that cough for more
than 2 weeks and do not respond to nonspecific antibiotics.
These patients are referred to the central laboratory at the
Palestinian Ministry of Health for microbiological testing.
Three sputum samples are collected from each patient for
microscopic examination and culture using the conven-
tional Lowenstein-Jensen (L-J) media. Although conven-
tional microbiology still constitutes the principal tool for the
diagnosis of TB and appropriate for laboratories with min-
imal infrastructure, direct microscopy testing has low sensi-
tivity [5], and culture requires a long period of time, leading
to significant delays in diagnosis and treatment, which gives
rise to development of drug resistance [6]. Therefore, early
diagnosis, effective treatment and identifying factors influ-
encing disease dynamics are major features in the control of
TB in our region. A detailed genetic study of the regional
MTB isolates, identification of the genotypes associated with
drug resistance and specifically evaluation of the appearance
of new MDR-TB strains in the studied population can facili-
tate both a more effective drug therapy regime and give in-
formation at the molecular epidemiological level. The goal
of our study was to identify and molecularly characterize
the MTB strains circulating in the Palestinian Territories for
further TB management programs.
Methods
Patient’s characteristics and clinical specimens
Overall 53 DNA samples were studied: 22 clinical
isolates that were retrieved from sputum samples and31-Ziehl Nelseen (ZN) stained sputum smears collected
during 2005–2010. All isolates were identified as MTB,
except of two that were M. bovis [7]. Smears and their
corresponding isolates were retrieved from 31 pul-
monary TB patients originating from 8 different dis-
tricts across the Palestinian Territories (Figure 1) and
were diagnosed on the basis of clinical symptoms,
chest X ray and bacteriological examination. All the
patients were diagnosed as TB positive based on the
smear test. Among them, 9 patients were under TB
therapy at the time of sampling and were found cul-
ture negative. Twenty-nine patients were adults
(18-71 years) and two were children (2 and 4 years
old). Out of the 31 patients, 16 were males and 15
were females giving a sex ratio of 1.1:1. Of all cases,
eight patients (26 %) had newly diagnosed TB in
2010. It is important to note that although the sample
size is relatively small, compared to other TB studies,
it comprised the largest sample available in the last
5 years in the West Bank including all the smear
positive cases of pulmonary TB that were reported by
the Palestinian ministry of health in 2009–2010
(n = 11).
Since this study involved analysis of archival samples
and clinical isolates obtained during routine diagnostic
work, patients were not asked to give their informed
consent. However, Al-Quds University ethics committee
approved the study protocol.
Spoligotyping
All samples (22 clinical isolates and 31 ZN- stained
smears) were analyzed by spoligotyping as previously
described [2]. The direct repeat (DR) region was ampli-
fied using DRa and DRb primers. The amplified biotiny-
lated products hybridized to a set of 43 oligonucleotides
covalently bound to a membrane (Isogen Life Science B.
V., Utrecht, The Netherlands). The hybridized PCR pro-
ducts were then incubated with streptavidin-peroxidase
conjugate. The membrane was incubated in chemolumi-
nescence substrate (Amersham, Little Chalfont, England),
then it was exposed to X-ray film (Hyperfilm ECL, Amer-
sham) according to the manufacturer’s instruction. For
reproducibility and specificity of the spoligotyping; dupli-
cate samples (the slides and their corresponding isolates)
together with known strains (H37Rv and M. bovis BCG)
were tested.
Analysis of M. tuberculosis specific deletion 1 (TbD1)
The presence or absence of MTB specific deletion
(TbD1) was analyzed by PCR as previously described [8].
Two PCR’s were performed for each sample using either
primers complementary to the internal sequences of the
TbD1 region or primers complementary to the
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Figure 1 Distribution of Mycobacterium tuberculosis strains in the West Bank, Palestinian Territories during 2005–2010. The MTB strains,
defined by spoligotyping, are listed in each district. * =Unknown MTB lineages. Number of patients studied and the sex ratios [males:females] are
included per district.
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of tandem repeat (MIRU-VNTR)
The 15-loci MIRU-VNTR typing was conducted as
described previously [1]. Several attempts to apply the
15-loci MIRU-VNTR typing on DNA extracts
obtained from ZN-stained slides failed and thus it was
applied only on DNA samples obtained from cultured
bacteria (n = 22). For three relapse patients, an add-
itional seven isolates were analyzed to replicate and
further support the results. Each locus was amplified
individually. The PCR fragments were separated by
electrophoresis using 2 % NuSieve gel. The fragments
size was estimated by comparison with 50 bp and
100 bp DNA molecular weight ladders and was inde-
pendently checked visually by two investigators. The
table used for MIRU-VNTR allele scoring is available
online in the technical guide ((supply 2005), http://
www.miru-vntrplus.org/MIRU/index.faces).Genetic detection of the KatG S315T mutation by direct
sequencing
All samples (n = 31) were analyzed for the presence of
KatG S315T mutation that is known to be associated
with INH resistance. A partial gene sequence of the katG
gene targeting the G to C substitution at codon 315 was
amplified and sequenced as previously described [9].
Results
Spoligotyping and TbD1 region
Spoligotyping was used to characterize the strain of all
samples (n = 31). In addition, all samples were tested for
presence of the TbD1 region, and as expected, this re-
gion was identified in two M. bovis strains. Interestingly,
one MTB isolate (477777277413771) also harbored the
TbD1 region, which was further characterized by pres-
ence of DR spacer 33 and absence of spacers 29–32 and
34 (Table 1).
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slides were completely identical to those obtained from
their corresponding culture isolates. For the 31 samples
analyzed, a total of 17 different patterns were found
(Table 1), of them, 13 isolates had unique patterns (they
did not match with another strain within this study).
Among these patterns, two isolates (777777377660771
and 037637037760771) were orphan types; they had noTable 1 Description of spoligotyping defined lineages/subline
residing in the West Bank/Palestinian territories, their propor




































Note that SIT3348* was "newly created” within this study. Lineage designations wer
that did not belong to known lineages described in the database; TUR (Turkey) desi
[11].homologue in the SITVIT2 database. A single shared-
type SIT3348 was "newly created" based on a single
strain from this study that matched an orphan in the
database from Pakistan (Table 1). The pattern obtained
was classified as “unknown” in SITVIT2, even though
the spoligotyping pattern of this strain resembles the
EAI lineage (with the exception of absence of spacer 33,
normally present in EAI). The TbD1 deletion found inages among M. tuberculosis strains isolated from patients
tion in study versus SITVIT2 database
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gnates the newly assigned Turkey lineage, previously classified as LAM7-TUR
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based on expert-based visual interpretation, the two or-
phan strains were tentatively assigned to T1 sublineage
and might result from microevolution of the circulating
T lineage genotypes.
The other 18 isolates analyzed by spoligotyping were
distributed in four clusters. The largest cluster (n = 11)
displayed a typical T1 spoligotype (SIT53). The second
cluster (n = 3) was the SIT4 genotype (previously
assigned to LAM 3 and S/convergent; a careful examin-
ation showed that its pattern did not correspond to any
well-defined lineages in SITVIT2, hence it was relabeled
“unknown”). The third cluster contained two isolates of
SIT1 belonging to the Beijing genotype while the fourth
cluster (n = 2) belonged to SIT482 M. bovis (BOV_1 sub-
lineage; Table 1).MIRU-VNTR
The 15-loci MIRU-VNTR typing results were available
for 22 culture isolates. A total of 19 distinct patterns
were acquired. Three clusters of two isolates each were
obtained but the majority of isolates (n = 16) did not
cluster (Figure 2). The 15-loci MIT144 and 145 were
newly created within this study, while the 15-loci
MIT142 was already reported in four MTB clinical iso-
lates in the database. No discrepancies were found be-
tween MIRU-VNTR classified patterns in multiple
isolates from the same patient corresponding to relapses
at different time points. Thus the second episodes of TBS
Figure 2 Genetic relationships among the TB isolates as revealed by M
vntrplus.org/MIRU/index.faces) was used for the phylogentic tree analysis. M
with in this study. The underlined loci represented single and double locuswere probably due to reactivation of the indigenous
strain revealing the stability and reproducibility of the
MIRU-VNTR typing.Genetic detection of drug resistance strains
In this study, the substitution known to be associated
with INH resistance at codon 315 [S (AGC) to T (ACC)]
was identified in the Beijing and LAM 9 isolates. One
representative sequence was deposited in the GenBank
(Accession no. JN411081). The mutation was not found
in all of the other 28 isolates, representing various geno-
types. Identification of the LAM 9 and Beijing isolates as
drug resistance strains was further supported by our pre-
vious study that characterized the hot spot region of
rpoB gene [5]. Two mutations (S< 531> L and L< 572
> F) were found in the two Beijing strains and one
double mutation (S< 531> F) was identified in one
strain belonged to the LAM 9 family that are known to
be associated with drug resistance [5].Synthesis of the characterization methods
Comparison of the results from the molecular
characterization methods was conducted on 22 isolates.
The 15-loci MIRU-VNTR analysis confirmed the cluster-
ing results obtained by the spoligotyping for only two
clusters (SIT1 and SIT482M. bovis). The two isolates
(PAL-I1, PAL-I16) that were identified as Beijing strain,
SIT1, via spoligotyping (Table 1) exhibited identical


























IRU-VNTRs. The online resource MIRU-VNTRplus (http://www.miru-
IT: MIRU International Type. MIT144 and MIT145 were newly created
variants of MIT144.
Ereqat et al. BMC Research Notes 2012, 5:270 Page 6 of 8
http://www.biomedcentral.com/1756-0500/5/270(Figure 2). The mutations found in the rpoB and KatG
genes supported the identification of these strains as
MDR. The two patients, represented by these isolates,
were not related to each other, they lived in two different
districts, infected in different years (2007 and 2010) and
were treated in different clinics. In addition, the two iso-
lates that matched SIT482, M. bovis strain, had identical
MIRU-VNTR patterns and were identified as MIT145
(Figure 2). Moreover, the TbD1 region that characterizes
M. bovis was identified in these isolates. These isolates
were obtained from two cousins who were children, one
of them was infected in 2006 and the other in 2010.
Additional information that may help in understanding
the transmission of the infection is unavailable.
However, the two clusters identified by spoligotyping
as SIT4 and T1 family strains (SIT53) (Table 1) were not
supported by the MIRU-VNTR analysis. The three iso-
lates, identified as SIT4 by spoligotyping, were found to
differ from each other and typed to three unique pat-
terns by the MIRU-VNTR genotyping. These isolates
were obtained from three unrelated patients who live in
three separated districts, lacking any known epidemio-
logical link.
The four isolates identified as T1 family strains (SIT53)
via spoligotyping, were typed by MIRU-VNTR as
MIT144 and variants of MIT144 (Figure 2). Among
them, two isolates (PAL-I4, PAL-I9) identified as
MIT144 were obtained from two close contacts that
were diagnosed and treated in the same clinic. The other
two isolates (PAL-I15, PAL-I25) represented single and
double locus variants of MIT144 (Figure 2), without any
clear epidemiological link between the patients.
Discussion
In the present study, genetic analyses by spoligotyping
and 15-loci MIRU-VNTR typing were determined to re-
veal the molecular genetic features of MTB strains circu-
lating in the West Bank.
The predominant genotype found in the West Bank
was that of SIT53-T1 (n = 11) known as an ubiquitous
spoligotype. Our findings are consistent with other stud-
ies, which indicate that SIT53-T1 is the most frequent
strain found in America, Europe, Asia and Africa. Al-
though the T family is one of the most prevalent world-
wide, it remains an ill-defined family of MTB, which
needs to be further characterized [10].
The results obtained with spoligotyping in our study
suggested a possible epidemiological link between three
patients whose isolates displayed the same spoligotyping
patterns (SIT4). However, when these isolates were typed
by MIRU-VNTR, they showed different diverse patterns.
The 15-loci MIRU-VNTR typing significantly reduced
the number of epidemiological links among the studied
isolates while spoligotyping overestimated these links.These differences between the two typing methods were
found in other published studies [12,13] indicating that
MIRU-VNTR typing is more powerful tool for molecular
epidemiological studies of MTB. In several cases the spo-
ligotyping and the MIRU-VNTR identified the same
MTB strain: for example the identification of the Beijing
(SIT1/MIT142) and M. bovis strains. Interestingly, all the
15-loci MIT142 strains (n = 6) in the SITVIT database
belong to the Beijing lineage, i.e., SIT1/Beijing are repre-
sented by five cases, and SIT190/Beijing represented by
one case.
We believe that using the 24-loci MIRU-VNTR, could
further increase the discriminatory power of this method
particularly for homogenous strains such as the M. bovis
and Beijing strains [1,14]. Moreover, a more detailed
identification of the strains will assist in determining the
dynamic of the MTB strains in the West Bank especially
introduction of new MTB strains in the region.
The study of theTbD1 region showed that the major-
ity of isolates (n = 28) belonged to the TbD1 deleted
modern strains, whereas only 3 strains (two M. bovis
and one EAI strain) had TbD1 intact. However, all EAI
strains that had the TbD1 region were designated ances-
tral MTB strains since they belong to a lineage that split
from MTB strains before the deletion of TbD1 occurred
[15]. Other interesting strains that were identified in
this study: (i) one strain belonging to the Manu family;
this strain was obtained from a non-local patient from
Indonesia who visited the West Bank and was under
treatment at the time of sampling; (ii) one strain of the
CAS family (sample PAL-I5), which is thought
to represent a possible ancestor of the Beijing family
[10]; and (iii) strains from Haarlem (H1, H3), T2, TUR
and LAM 9 families. Overall, 19 different strains
(as revealed by MIRU-VNTR typing) were detected
from various communities located in different areas in
the West Bank. The different genotypes which were
found in our region (Figure 1), that are represented in
many geographical regions worldwide, supports world
globalization.
The Beijing and LAM 9 strains that were identified
among the studied isolates were further found to carry
the mutations along the katG and the rpoB genes known
to be associated with drug resistance [5,9] and thus were
considered as MDR-TB strains. It is important to note
that these strains were obtained from three unrelated
patients who did not respond to the first line of anti-
tuberculosis drugs regimen. However, both genotypes
(the Beijing and LAM) showed MDR phenotype associ-
ation in other studies [16,17]. As drug susceptibility test-
ing has not been applied yet in the West Bank,
treatment failure and suspicious drug resistance cases
are referred to neighboring countries for further investi-
gations. Based on epidemiologic data, Beijing family
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strains, enabling aggressive expanding among the popu-
lation [18]. Therefore, the finding of Beijing strain in the
Palestinian Territories underlines the emergence of
Beijing genotype in the region, which constitutes a major
public health risk in a vulnerable population and reinfor-
cing the need to raise awareness of the disease in the re-
gion. Our results suggests that the genetic screening for
the hot spot region of the rpoB and the S315T katG mu-
tation may rapidly provide information for anti-TB regi-
men selection and possibly assist in tracing transmission
of MDR strains.
Conclusions
This study presents the first overview of M. tuberculosis
genotypes circulating in the West Bank Palestinian Terri-
tories using two different molecular typing methods. In
addition, it provides preliminary insight into the molecu-
lar diversity of the studied population including identifi-
cation of mutations associated with the development of
resistance to RIF and INH, belonging to a certain myco-
bacterial genotype.
The genotyping obtained in this study represents an
early attempt to establish a database of strain types cir-
culating in our region. This database will enable us to
trace the relationships among strains, to restrict the
chain of transmission between different communities, re-
veal the sources of infection and facilitate the implemen-
tation of effective TB control program. Further studies
may provide a better understanding of the molecular epi-
demiology and biodiversity of M. tuberculosis in the
region.
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